Literature DB >> 19586056

Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.

Yingge Liu1, Stephanie M Stanford, Sonali P Jog, Edoardo Fiorillo, Valeria Orrú, Lucio Comai, Nunzio Bottini.   

Abstract

The lymphoid tyrosine phosphatase LYP, encoded by the PTPN22 gene, recently emerged as a major player and candidate drug target for human autoimmunity. The enzyme includes a classical N-terminal protein tyrosine phosphatase catalytic domain and a C-terminal PEST-enriched domain, separated by an approximately 300-amino acid interdomain. Little is known about the regulation of LYP. Herein, by analysis of serial truncation mutants of LYP, we show that the phosphatase activity is strongly inhibited by protein regions C-terminal to the catalytic domain. We mapped the minimal inhibitory region to the proximal portion of the interdomain. We show that the activity of LYP is inhibited by an intramolecular mechanism, whereby the proximal portion of the interdomain directly interacts with the catalytic domain and reduces its activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586056      PMCID: PMC3113683          DOI: 10.1021/bi900332f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP.

Authors:  A Gjörloff-Wingren; M Saxena; S Williams; D Hammi; T Mustelin
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

2.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes.

Authors:  Magdalena Zoledziewska; Chiara Perra; Valeria Orrù; Loredana Moi; Paola Frongia; Mauro Congia; Nunzio Bottini; Francesco Cucca
Journal:  Diabetes       Date:  2007-10-12       Impact factor: 9.461

Review 4.  PTPN22: setting thresholds for autoimmunity.

Authors:  Peter K Gregersen; Hye-Soon Lee; Franak Batliwalla; Ann B Begovich
Journal:  Semin Immunol       Date:  2006-05-30       Impact factor: 11.130

Review 5.  Role of PTPN22 in type 1 diabetes and other autoimmune diseases.

Authors:  Nunzio Bottini; Torkel Vang; Francesco Cucca; Tomas Mustelin
Journal:  Semin Immunol       Date:  2006-05-11       Impact factor: 11.130

6.  Association of protein-tyrosine phosphatase MEG2 via its Sec14p homology domain with vesicle-trafficking proteins.

Authors:  Kan Saito; Scott Williams; Anna Bulankina; Stefan Höning; Tomas Mustelin
Journal:  J Biol Chem       Date:  2007-03-26       Impact factor: 5.157

7.  Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes.

Authors:  Mary Rieck; Adrian Arechiga; Suna Onengut-Gumuscu; Carla Greenbaum; Patrick Concannon; Jane H Buckner
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.

Authors:  Xiao Yu; Jin-Peng Sun; Yantao He; Xiaoling Guo; Sijiu Liu; Bo Zhou; Andy Hudmon; Zhong-Yin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

9.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

10.  Large-scale structural analysis of the classical human protein tyrosine phosphatome.

Authors:  Alastair J Barr; Emilie Ugochukwu; Wen Hwa Lee; Oliver N F King; Panagis Filippakopoulos; Ivan Alfano; Pavel Savitsky; Nicola A Burgess-Brown; Susanne Müller; Stefan Knapp
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  11 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.

Authors:  Stephanie M Stanford; Tomas M Mustelin; Nunzio Bottini
Journal:  Semin Immunopathol       Date:  2010-03-04       Impact factor: 9.623

Review 3.  PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy.

Authors:  Brenson A Jassim; Jianping Lin; Zhong-Yin Zhang
Journal:  Expert Opin Drug Discov       Date:  2022-06-07       Impact factor: 7.050

Review 4.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

Review 5.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

6.  PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis.

Authors:  Hui-Hsin Chang; Tzong-Shyuan Tai; Bing Lu; Christine Iannaccone; Manuela Cernadas; Michael Weinblatt; Nancy Shadick; Shi-Chuen Miaw; I-Cheng Ho
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 7.  Risk factors and primary prevention trials for type 1 diabetes.

Authors:  Yan-Ling Wu; Yan-Ping Ding; Jian Gao; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Biol Sci       Date:  2013-07-18       Impact factor: 6.580

8.  Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.

Authors:  Heather I Fraser; Sarah Howlett; Jan Clark; Daniel B Rainbow; Stephanie M Stanford; Dennis J Wu; Yi-Wen Hsieh; Christian J Maine; Mikkel Christensen; Vijay Kuchroo; Linda A Sherman; Patricia L Podolin; John A Todd; Charles A Steward; Laurence B Peterson; Nunzio Bottini; Linda S Wicker
Journal:  J Immunol       Date:  2015-10-05       Impact factor: 5.422

9.  Altered expression of protein tyrosine phosphatase, non-receptor type 22 isoforms in systemic lupus erythematosus.

Authors:  Hui-Hsin Chang; William Tseng; Jing Cui; Karen Costenbader; I-Cheng Ho
Journal:  Arthritis Res Ther       Date:  2014-01-17       Impact factor: 5.156

10.  Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto's thyroiditis.

Authors:  Licheng Gong; Beihong Liu; Jing Wang; Hong Pan; Anhui Qi; Siyang Zhang; Jinyi Wu; Ping Yang; Binbin Wang
Journal:  BMC Endocr Disord       Date:  2018-11-01       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.